20 Years of Human Pluripotent Stem Cells: Current Clinical Trials and Regulatory Framework
April 18, 2018 | Madison, WI
Over the years, the BTC Institute has partnered with the Stem Cell & Regenerative Medicine Center, at the University of Wisconsin-Madison to offer this packed day of excellent talks and opportunities to interact with renowned speakers, poster session presenters, sponsor representatives and other attendees.
Our UW-Madison committee members define each year’s content and pull together a strong group of presenters. This year, we’re working with Timothy J. Kamp, M.D. (Professor, Medicine, Cell and Regenerative Biology; Co-director, Stem Cell and Regenerative Medicine Center), William L. Murphy, Ph.D. (Professor, Biomedical Engineering, Orthopedics & Rehabilitation; Co-director, Stem Cell & Regenerative Medicine Center) and James Thomson, Ph.D. (John D. MacArthur Professor, Director, Regenerative Biology, Morgridge Institute for Research; Professor, Department of Molecular, Cellular, & Developmental Biology, University of California – Santa Barbara).
Our 2018 symposium brings together leading researchers advancing human pluripotent stem cell products to clinical applications for a range of degenerative diseases. Progress in clinical trials, as well as major barriers for developing these revolutionary new therapies will be discussed.
As Dr. Kamp notes, “This will be a remarkable meeting highlighting the emerging field of regenerative medicine which has grown from the pioneering discovery of human embryonic stem cells 20 years ago.” Continue reading “Announcing the 13th Annual Wisconsin Stem Cell Symposium”
As an animal lover who has been passionate about genetic conservation approaches since I first heard about the “Cheetah papers” over twenty years ago, I am excited at the work highlighted in two papers published in the last year that have begun the process of applying induced pluripotent stem cell (iPSC) technologies to endangered animals (1,2). 